Johnson & Johnson to Host Medical Devices & Diagnostics Review

NEW BRUNSWICK, N.J., Oct. 25, 2012 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a Medical Devices & Diagnostics business review for the investment community beginning at 8:30 a.m. (Eastern Time) on Thursday, November 1st at the Hyatt Regency Hotel in New Brunswick, N.J.

The program will include presentations by Johnson & Johnson's senior management representing our Medical Devices & Diagnostics segments.  Dominic Caruso, Vice President, Finance and Chief Financial Officer will open the meeting.  

A live webcast will be available through www.investor.jnj.com.  This webcast is optimized for mobile streaming on iOS devices such as iPhones, iPods, and iPads.  A replay and podcast will be available approximately two hours after the meeting concludes.

SOURCE Johnson & Johnson

Suggested Articles

Stephen Hahn, an oncologist who served as the chief medical officer for the MD Anderson Cancer Center, has secured Senate confirmation as FDA head.

As BMS searches for bright spots in its Opdivo-chemo combo fail from June, it’s zeroing in on squamous lung cancer patients who seemed to benefit.

The FDA's ad watchdog served its most serious violation to Alkermes Wednesday—and it took the unusual step of announcing that violation to the world.